12:00 AM
Apr 15, 2013
 |  BC Week In Review  |  Clinical News  |  Clinical Status

APD334: Phase I started

Arena began a double-blind, placebo-controlled Phase I trial to evaluate single ascending-doses of APD334 in up to...

Read the full 61 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >